| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |